Last reviewed · How we verify
Spinal morphine 0.05 mg
Spinal morphine 0.05 mg, developed by Mahidol University, is a marketed drug with a key composition patent expiring in 2028. The drug's market position and primary indication are not specified, but it leverages a well-established mechanism of action for pain management. The primary risk is the patent expiry in 2028, which could lead to increased competition from generics.
At a glance
| Generic name | Spinal morphine 0.05 mg |
|---|---|
| Also known as | opioids |
| Sponsor | Mahidol University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Analgesic Efficacy of Multiple Mid-Transverse Process to Pleura (MTP) Block and PCA in Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion (NA)
- Height Adjusted Versus Standardized Dose of Bupivacaine for Spinal Anesthesia (NA)
- Evaluation and Comparison Between General Anesthesia VS Two Types of Combined Anesthesia for Opioid Consumption in Laparoscopic Hysterectomy (NA)
- Measuring Sleep Quality In Patients That Posterior Spinal Instrumentatıon Plannıng (NA)
- Phenylephrine Versus Norepinephrine for Maintenance of Hemodynamic During Cesarean Section Under Spinal Anesthesia (PHASE4)
- Duloxetine Potentiates the Analgesic Efficacy of Intrathecal Morphine (NA)
- Spinal Morphine Provides an Effective Pain Control in Patients Undergoing Transurethral Resection of Prostate Gland (NA)
- Intermittent Epidural Bolus Versus Epidural Infusion for Posterior Spinal Fusion After Adolescent Idiopathic Scoliosis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Spinal morphine 0.05 mg CI brief — competitive landscape report
- Spinal morphine 0.05 mg updates RSS · CI watch RSS
- Mahidol University portfolio CI